196 related articles for article (PubMed ID: 24735096)
1. Does Alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, India.
Duraisamy K; Mrithyunjayan S; Ghosh S; Nair SA; Balakrishnan S; Subramoniapillai J; Oeltmann JE; Moonan PK; Kumar AM
Ann Am Thorac Soc; 2014 Jun; 11(5):712-8. PubMed ID: 24735096
[TBL] [Abstract][Full Text] [Related]
2. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.
Cavanaugh JS; Kazennyy BY; Nguyen ML; Kiryanova EV; Vitek E; Khorosheva TM; Nemtsova E; Cegielski JP
Int J Tuberc Lung Dis; 2012 Aug; 16(8):1069-74. PubMed ID: 22691694
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
Gadallah MA; Mokhtar A; Rady M; El-Moghazy E; Fawzy M; Kandil SK
J Formos Med Assoc; 2016 Nov; 115(11):997-1003. PubMed ID: 26696497
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
6. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
[TBL] [Abstract][Full Text] [Related]
7. Study of treatment outcomes of multidrug-resistant tuberculosis under programmatic conditions and factors influencing the outcomes in Hyderabad District.
Kandi S; K TK; Kandi SR; Mathur N; D CD; Adepu R
Indian J Tuberc; 2021 Jul; 68(3):379-383. PubMed ID: 34099204
[TBL] [Abstract][Full Text] [Related]
8. Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil Nadu, India.
Nair D; Navneethapandian PD; Tripathy JP; Harries AD; Klinton JS; Watson B; Sivaramakrishnan GN; Reddy DS; Murali L; Natrajan M; Swaminathan S
Trans R Soc Trop Med Hyg; 2016 Sep; 110(9):534-541. PubMed ID: 27738284
[TBL] [Abstract][Full Text] [Related]
9. Previous treatment, sputum-smear nonconversion, and suburban living: The risk factors of multidrug-resistant tuberculosis among Malaysians.
Mohd Shariff N; Shah SA; Kamaludin F
Int J Mycobacteriol; 2016 Mar; 5(1):51-8. PubMed ID: 26927990
[TBL] [Abstract][Full Text] [Related]
10. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.
Javaid A; Ullah I; Masud H; Basit A; Ahmad W; Butt ZA; Qasim M
Clin Microbiol Infect; 2018 Jun; 24(6):612-617. PubMed ID: 28970158
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-EchevarrÃa A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
12. Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia.
Bastard M; Sanchez-Padilla E; Hewison C; Hayrapetyan A; Khurkhumal S; Varaine F; Bonnet M
J Infect Dis; 2015 May; 211(10):1607-15. PubMed ID: 25312040
[TBL] [Abstract][Full Text] [Related]
13. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation.
Miller AC; Gelmanova IY; Keshavjee S; Atwood S; Yanova G; Mishustin S; Furin JJ; Shin SS
Int J Tuberc Lung Dis; 2012 Jul; 16(7):891-6. PubMed ID: 22507895
[TBL] [Abstract][Full Text] [Related]
14. "Side effects--part of the package": a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India.
Jakasania A; Shringarpure K; Kapadia D; Sharma R; Mehta K; Prajapati A; Kathirvel S
BMC Infect Dis; 2020 Dec; 20(1):918. PubMed ID: 33267826
[TBL] [Abstract][Full Text] [Related]
15. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
Kliiman K; Altraja A
Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
[TBL] [Abstract][Full Text] [Related]
16. Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.
Lee J; Lee CH; Kim DK; Yoon HI; Kim JY; Lee SM; Yang SC; Lee JH; Yoo CG; Lee CT; Chung HS; Kim YW; Han SK; Yim JJ
Korean J Intern Med; 2011 Jun; 26(2):153-9. PubMed ID: 21716591
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance.
Jaber AAS; Ibrahim B
BMC Infect Dis; 2019 May; 19(1):464. PubMed ID: 31126246
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.
Franke MF; Appleton SC; Bayona J; Arteaga F; Palacios E; Llaro K; Shin SS; Becerra MC; Murray MB; Mitnick CD
Clin Infect Dis; 2008 Jun; 46(12):1844-51. PubMed ID: 18462099
[TBL] [Abstract][Full Text] [Related]
19. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
[TBL] [Abstract][Full Text] [Related]
20. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
